Evaluation of two methods of intravenous potassium infusion on the correction of hypokalemia in Critically Ill Patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20141009019470N102

Enrollment

Registered

2020-09-22

Start date

2020-10-22

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypokalemia. Hypokalemia

Interventions

Intervention 1: Intervention group:Administration of 20 mEq of potassium chloride as infusion over one hour. Intervention 2: Intervention group:Administration of 20 mEq of potassium chloride by infusi

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age 20 to 75 years Hospitalization in intensive care unit with blood potassium level 3.5-2.5

Exclusion criteria

Exclusion criteria: Heart disease kidney disease Diabetes High blood pressure Gastrointestinal inflammatory disease Diarrhea and vomiting Taking diuretics Potassium supplementation ACEI Consumption Bicarbonate Cardiac arrhythmia Use of inotropic drugs Acid and base disorder

Design outcomes

Primary

Measure	Time frame
Correction of blood potassium levels in patients with hypokalemia with 3-hour potassium infusion. Timepoint: A blood sample is taken from the patient to check the blood level of potassium1 hour, 3 hours and 6 hours after the end of the infusion,. Method of measurement: A blood sample.	—

Secondary

Measure	Time frame
Arrhythmia. Timepoint: 1 hour, 3 hours and 6 hours after the end of the infusion,. Method of measurement: Monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Zeinali

Shiraz University of Medical Sciences

nedaznl68@gmail.com+98 71 3647 4270

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026